ADC Therapeutics
ADCT
ADCT
52 hedge funds and large institutions have $921M invested in ADC Therapeutics in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $1B → $921M (-$79.6M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
99% less call options, than puts
Call options by funds: $3K | Put options by funds: $336K
Holders
52
Holding in Top 10
2
Calls
$3K
Puts
$336K
Top Buyers
| 1 | +$80.1M | |
| 2 | +$31.1M | |
| 3 | +$27.3M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$14.2M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$12.2M |
Top Sellers
| 1 | -$8.2M | |
| 2 | -$6.6M | |
| 3 | -$1.39M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$1.35M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$290K |